Patents by Inventor Willem E. Marissen

Willem E. Marissen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7959922
    Abstract: The present invention provides pharmaceutical antibody formulations, in particular liquid pharmaceutical formulations comprising anti-rabies virus antibodies. The formulations can be used in the post exposure prophylaxis of rabies.
    Type: Grant
    Filed: December 4, 2007
    Date of Patent: June 14, 2011
    Assignee: Crucell Holland B.V.
    Inventors: Alexander B. H. Bakker, Willem E. Marissen
  • Publication number: 20100034829
    Abstract: The present invention provides pharmaceutical antibody formulations, in particular liquid pharmaceutical formulations comprising anti-rabies virus antibodies. The formulations can be used in the post exposure prophylaxis of rabies.
    Type: Application
    Filed: December 4, 2007
    Publication date: February 11, 2010
    Applicant: Cruell Holland B.V.
    Inventors: Alexander B. H. Bakker, Willem E. Marissen
  • Patent number: 7579446
    Abstract: The invention provides binding molecules that specifically bind to rabies virus and are capable of neutralizing the virus. The invention further provides nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from rabies virus. Preferably, they can be used in the post-exposure prophylaxis of rabies.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: August 25, 2009
    Assignee: Crucell Holland B.V.
    Inventors: Alexander B. H. Bakker, Willem E. Marissen, Robert A. Kramer, Cornelius A. de Kruif